The arrival of Retatrutide ZPHC, at a concentration of 120mg, is creating considerable buzz within the weight loss community. This groundbreaking dual GIP and GLP-1 target medication appears to deliver significant improvements in body loss compared to existing therapies. Initial research trials have shown marked decreases in body fat percentage, co